Literature DB >> 29305934

Efficacy of Laparoscopic Nissen Fundoplication vs Transoral Incisionless Fundoplication or Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-analysis.

Joel E Richter1, Ambuj Kumar2, Seth Lipka3, Branko Miladinovic2, Vic Velanovich4.   

Abstract

BACKGROUND & AIMS: The effects of transoral incisionless fundoplication (TIF) and laparoscopic Nissen fundoplication (LNF) have been compared with those of proton pump inhibitors (PPIs) or a sham procedure in patients with gastroesophageal reflux disease (GERD), but there has been no direct comparison of TIF vs LNF. We performed a systematic review and network meta-analysis of randomized controlled trials to compare the relative efficacies of TIF vs LNF in patients with GERD.
METHODS: We searched publication databases and conference abstracts through May 10, 2017 for randomized controlled trials that compared the efficacy of TIF or LNF with that of a sham procedure or PPIs in patients with GERD. We performed a network meta-analysis using Bayesian methods under random-effects multiple treatment comparisons. We assessed ranking probability by surface under the cumulative ranking curve.
RESULTS: Our search identified 7 trials comprising 1128 patients. Surface under the cumulative ranking curve ranking indicated TIF had highest probability of increasing patients' health-related quality of life (0.96), followed by LNF (0.66), a sham procedure (0.35), and PPIs (0.042). LNF had the highest probability of increasing percent time at pH <4 (0.99), followed by PPIs (0.64), TIF (0.32), and the sham procedure (0.05). LNF also had the highest probability of increasing LES pressure (0.78), followed by TIF (0.72) and PPIs (0.01). Patients who underwent the sham procedure had the highest probability for persistent esophagitis (0.74), followed by those receiving TIF (0.69), LNF (0.38), and PPIs (0.19). Meta-regression showed a shorter follow-up time as a significant confounder for the outcome of health-related quality of life in studies of TIF.
CONCLUSIONS: In a systematic review and network meta-analysis of trials of patients with GERD, we found LNF to have the greatest ability to improve physiologic parameters of GERD, including increased LES pressure and decreased percent time pH <4. Although TIF produced the largest increase in health-related quality of life, this could be due to the shorter follow-up time of patients treated with TIF vs LNF or PPIs. TIF is a minimally invasive endoscopic procedure, yet based on evaluation of benefits vs risks, we do not recommend it as a long-term alternative to PPI or LNF treatment of GERD.
Copyright © 2018 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endoluminal; Esophagus; HRQOL; Hiatal Defect

Mesh:

Substances:

Year:  2018        PMID: 29305934     DOI: 10.1053/j.gastro.2017.12.021

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  22 in total

Review 1.  Endoscopic and Surgical Treatments for Achalasia: Who to Treat and How?

Authors:  Romulo A Fajardo; Roman V Petrov; Charles T Bakhos; Abbas E Abbas
Journal:  Gastroenterol Clin North Am       Date:  2020-06-26       Impact factor: 3.806

Review 2.  Advances in the Diagnosis and Treatment of GERD: New Tricks for an Old Disease.

Authors:  Rishi D Naik; Lauren Evers; Michael F Vaezi
Journal:  Curr Treat Options Gastroenterol       Date:  2019-03

Review 3.  Pathophysiology of gastroesophageal reflux disease: how an antireflux procedure works (or does not work).

Authors:  Fernando A M Herbella; Francisco Schlottmann; Marco G Patti
Journal:  Updates Surg       Date:  2018-07-23

4.  Endoscopic Approaches for the Treatment of Gastroesophageal Reflux Disease.

Authors:  Ronnie Fass
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-10

Review 5.  Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease.

Authors:  Rena Yadlapati; Kelli DeLay
Journal:  Med Clin North Am       Date:  2018-11-01       Impact factor: 5.456

6.  Update on Endoscopic Approaches for the Management of Gastroesophageal Reflux Disease.

Authors:  Zaheer Nabi; D Nageshwar Reddy
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-07

7.  Practice-Changing Milestones in Anti-reflux and Hiatal Hernia Surgery: a Single Surgeon Perspective over 27 years and 1200 Operations.

Authors:  Vic Velanovich
Journal:  J Gastrointest Surg       Date:  2021-02-02       Impact factor: 3.452

8.  Safe implementation of transoral incisionless fundoplication as a new technique in a tertiary care center.

Authors:  Shivanand Bomman; Sofya Malashanka; Adil Ghafoor; David J Sanders; Shayan Irani; Richard A Kozarek; Andrew Ross; Michal Hubka; Rajesh Krishnamoorthi
Journal:  Clin Endosc       Date:  2022-08-17

Review 9.  Recent Advances in the Endoscopic Management of Gastro-esophageal Reflux Disorder: A Review of Literature.

Authors:  Kunal Ajmera; Nigil Thaimuriyil; Nihar Shah
Journal:  Cureus       Date:  2022-06-22

Review 10.  Novel Therapies for Gastroesophageal Reflux Disease: Beyond Proton Pump Inhibitors.

Authors:  Fahmi Shibli; Yoshitaka Kitayama; Ronnie Fass
Journal:  Curr Gastroenterol Rep       Date:  2020-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.